NCT00814879 - Pilot Study of a Raltegravir Based NRTI Sparing Regimen | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

November 30, 2013

Conditions

Acquired Immune Deficiency SyndromeAIDSHuman Immunodeficiency VirusHIV Infections

Interventions

DRUG

Raltegravir

400 mg BID

DRUG

Atazanavir

300 mg BID

OTHER

Standard treatment regimen

N(t)RTI(s) based backbone plus ritonavir boosted PI

Trial Locations (5)

Comprehensive Care Center, Inc (dba Community AIDS Network), Sarasota

Yale University School of Medicine, New Haven

Saint Raphael Healthcare System, New Haven

Waterbury Hospital, Waterbury

VA CT Healthcare Systems, West Haven